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Abstract
Causal inference with observational studies often relies on the assumptions of unconfoundedness and
overlap of covariate distributions in different treatment groups. The overlap assumption is violated when
some units have propensity scores close to 0 or 1, and therefore both practical and theoretical researchers
suggest dropping units with extreme estimated propensity scores. However, existing trimming methods
ignore the uncertainty in this design stage and restrict inference only to the trimmed sample, due to the
non-smoothness of the trimming. We propose a smooth weighting, which approximates the existing sample
trimming but has better asymptotic properties. An advantage of the new smoothly weighted estimator
is its asymptotic linearity, which ensures that the bootstrap can be used to make inference for the target
population, incorporating uncertainty arising from both the design and analysis stages. We also extend
the theory to the average treatment effect on the treated, suggesting trimming samples with estimated
propensity scores close to 1.
Some key words: Bootstrap; Lack of overlap; Non-smoothness; Potential outcome; Unconfoundedness.
1 Introduction
Under the potential outcomes framework, there is an extensive literature on estimating causal effects based
on the assumptions of unconfoundedness and sufficient overlap in the covariate distributions (Rosenbaum
and Rubin; 1983; Angrist and Pischke; 2008; Imbens and Rubin; 2015). Unfortunately, in many applications
it is common to have limited overlap in covariates between the treatment and control groups, which affects
the credibility of all methods attempting to estimate causal effects for the population (King and Zeng; 2005;
Imbens; 2015). A consequence in weighting is that extreme propensity scores induce large weights, which
can result in a large variance and poor finite sample properties (Kang and Schafer; 2007; Khan and Tamer;
2010). Therefore, it is desirable to modify the estimand to averaging only over the part of the covariate space
with treatment probabilities bounded away from 0 and 1. For example, in a medical study of a particular
chemotherapy for breast cancer, because patients with stage I breast cancer have never been treated with
chemotherapy, clinicians then redefine the study population to be patients with stage II to stage IV breast
cancer, omitting patients with stage I breast cancer for whom the propensity score is 0. This effectively alters
the estimand by changing the reference population to a different target population. Li et al. (2016) proposed
a general representation for the target population.
Trimming observational studies based on estimated propensity scores was first used in medical applications
(e.g., Vincent et al.; 2002; Grzybowski et al.; 2003; Kurth et al.; 2005) and then formalized by Crump et al.
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(2009). Based on the estimation efficiency, Crump et al. (2009) suggested dropping units from the analysis
with estimated propensity score outside an interval [α1, α2], so that the average treatment effect for the
target population can be estimated with the smallest asymptotic variance. Other methods, e.g., Traskin and
Small (2011) and Fogarty et al. (2016), construct the study population based on covariates themselves. But
with moderate or high dimensional covariates, these rules for discarding units become complicated. In these
cases, dimension reduction, for example, seeking for a scalar summary of the covariates, seems important.
This was the original motivation of the propensity score (Rosenbaum and Rubin; 1983), which is auguably
the most interpretable scalar function of the covariates. Since 1983, Rosenbaum and Rubin’s paper has been
cited for more than 18, 000 according to Google Scholar.
Importantly, existing methods, including Crump et al. (2009), Traskin and Small (2011) and Fogarty et al.
(2016), ignored the uncertainty in this design stage and restricted inference only to the trimmed sample. In
contrast, we incorporate uncertainty in both the design and analysis stages. The non-smooth nature of
trimming renders the target causal estimand not root-n estimable (Crump et al.; 2009). Therefore, instead
of making a binary decision to include or exclude units from analysis, we propose to use a smooth weight
function so that all units are weighted continuously. This smooth weighting approximates the existing sample
trimming, but allows us to derive the asymptotic properties of the corresponding causal effect estimators
using conventional linearization methods for two-step statistics. We formally show that the new weighting
estimators are asymptotically linear, and thus the bootstrap can be used to construct confidence intervals,
reflecting the uncertainty in both the design and analysis stages. Nevertheless, we do not argue against other
tools for selecting targeted populations, but provide a template to account for uncertainty in the design of
observational studies.
2 Potential outcomes, causal effects and assumptions
For each unit i, the treatment is Ai ∈ {0, 1}, where 0 and 1 are labels for control and treatment. There
are two potential outcomes, one for treatment and the other for control, denoted by Yi(1) and Yi(0), respec-
tively. The observed outcome is Yi = Yi(Ai). Let Xi be the observed pre-treatment covariates. We assume
that {Ai, Xi, Yi(1), Yi(0)}Ni=1 are independent draws from the distribution of {A,X, Y (1), Y (0)}. Given the
observed covariates, the conditional average causal effect is τ(X) = E{Y (1) − Y (0) | X}. The average
treatment effect is τ = E{Y (1)− Y (0)} = E{τ(X)}. The common assumptions to identify τ are as follows
(Rosenbaum and Rubin; 1983).
Assumption 1 (Unconfoundedness) Y (a)⊥A | X for a = 0, 1.
Assumption 2 (Sufficient overlap) There exist constants c1 and c2 such that with probability 1, 0 < c1 ≤
e(X) ≤ c2 < 1, where e(X) = pr(A = 1 | X) is the propensity score.
In observational studies, the propensity score is not known and therefore has to be estimated from data.
Following Rosenbaum and Rubin (1983) and most of the empirical literature, we assume that the propensity
score is correctly specified by a generalized linear model e(X) = e(X ′θ∗). We focus on θˆ, the maximum
likelihood estimator of the true parameter θ∗, although our method is also applicable to other asymptotically
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linear estimators of θ∗. Then, a simple weighting estimator of τ is N−1
∑N
i=1 τˆ(Xi), where
τˆ(Xi) =
AiYi
e(X ′i θˆ)
− (1−Ai)Yi
1− e(X ′i θˆ)
.
If we further estimate µ(a,X) = E(Y | A = a,X) by µˆ(a,X) and obtain the residual Rˆi = Yi − µˆ(Ai, Xi),
then the augmented weighting estimator is N−1
∑N
i=1 τˆ
aug(Xi) (Lunceford and Davidian; 2004; Bang and
Robins; 2005), where
τˆaug(Xi) =
{
AiRˆi
e(X ′i θˆ)
+ µˆ(1, Xi)
}
−
{
(1−Ai)Rˆi
1− e(X ′i θˆ)
+ µˆ(0, Xi)
}
.
The augmented weighting estimator features a double robustness property in the sense that under Assump-
tions 1 and 2, it is consistent for τ if either e(X) or µ(a,X) is correctly specified.
The weighting estimators suffer from a large variability when Assumption 2 is violated or close to be
violated. In the presence of lack of overlap, define the set with sufficient overlap to be O = {X | α1 ≤
e(X) ≤ α2}, where α1 and α2 are fixed cut-off values; e.g., a rule of thumb suggests α1 = 0.1 and α2 = 0.9
(Crump et al.; 2009). The target population is then represented by O, and the estimand of interest becomes
τ(O) = E{τ(X) | X ∈ O}. The trimmed sample based on the estimated propensity score is Oˆ = {X | α1 ≤
e(X ′θˆ) ≤ α2}. Correspondingly, the inclusion weight is
ω(X ′i θˆ) = 1{α1 ≤ e(X ′i θˆ) ≤ α2}, (1)
where 1{·} is the indicator function, and the weighting estimators of τ(O) become
τˆ = τˆ(θˆ) =
{
N∑
i=1
ω(X ′i θˆ)
}−1 N∑
i=1
ω(X ′i θˆ)τˆ(Xi), (2)
τˆaug = τˆaug(θˆ) =
{
N∑
i=1
ω(X ′i θˆ)
}−1 N∑
i=1
ω(X ′i θˆ)τˆ
aug(Xi). (3)
The main question addressed in this article is how the estimated support affects the inference. Crump
et al. (2009) ignored the uncertainty in estimating O and restricted inferences only for τ(Oˆ) rather than
τ(O). To make inference for τ(O), we need to take into account first the sampling variability in θˆ, which
induces variability of the estimated set Oˆ and second the sampling variability in τˆ and τˆaug. We can not
directly apply conventional asymptotic linearization methods because the weight function (1) is non-smooth.
To avoid this difficulty, we consider a smooth weight function
ω(X
′
i θˆ) = Φ
{
e(X ′i θˆ)− α1
}
Φ
{
α2 − e(X ′i θˆ)
}
, (4)
where Φ(z) is a normal cumulative distribution with mean zero and variance 2. The normal distribution
is can be changed to any distribution as long as it is differentiable and its variance increases with . See
Figure 1 for a visualization of different weight functions. As → 0, the smooth weight function (4) converges
to the indicator weight function (1). Both the smooth and indicator weight functions include units with
non-extreme propensity scores with probability 1. In contrast, another smooth weight function, the overlap
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Fig. 1. Weight functions: the solid line is 1{0.1 ≤ e ≤ 0.9}; the thick dot and dash lines are the smooth weight function
ω(e) with  = 0.0001 and  = 0.001, respectively; the thin dash line is the overlap weight function ω(e) ∝ e(1− e) in
Li et al. (2016) up to some constant.
weight function ω{e(X)} = e(X){1 − e(X)} recently proposed by Li et al. (2016), overweighs units with
propensity scores close to 0.5 and thus does not target τ(O).
3 Main Results for the average causal effect
We derive the asymptotic results for the smooth weighting estimators. Based on data {(Ai, Xi)}Ni=1, let the
score function and the Fisher information matrix of θ be
S(θ) =
1
N
N∑
i=1
Xi
Ai − e(X ′iθ)
e(X ′iθ){1− e(X ′iθ)}
f(X ′iθ), I(θ) = E
[
f(X ′θ)2
e(X ′θ){1− e(X ′θ)}XX
′
]
,
where f(t) = de(t)/dt. Let σ2(a,X) = var(Y | A = a,X) for a = 0, 1. Denote by τˆ and τˆaug the weighting
estimators (2) and (3) with the smooth weight function (4), respectively. Let τ = E{ω(X ′θ∗)τ(X)} and
ω(θ) = E{ω(X ′θ)}. We show that τˆ and τˆaug are consistent for τ. Moreover, the discrepancy between τ
and the target estimand τ(O) can be made arbitrarily small by choosing a small .
Theorem 1 Under Assumption 1, τˆ is asymptotically linear. Moreover,
N1/2(τˆ − τ)→ N
{
0, σ2 + b
′
1,I(θ∗)−1b1, − b′2,I(θ∗)−1b2,
}
,
in distribution, as N →∞, where
b1, = E
[
∂
∂θ
{
ω(θ
∗)−1ω(X ′θ∗)
}
τ(X)
]
,
b2, = ω(θ
∗)−1E
{
ω(X
′θ∗)f(X ′θ∗)
[
E{Xµ(1, X) | e(X)}
e(X)
+
E{Xµ(0, X) | e(X)}
1− e(X)
]}
,
σ2 = ω(θ
∗)−2E[ω(X ′θ∗)2var{τ(X)}]
+ω(θ
∗)−2E
ω(X ′θ∗)2
[{
1− e(X)
e(X)
}1/2
µ(1, X) +
{
e(X)
1− e(X)
}1/2
µ(0, X)
]2
+ω(θ
∗)−2E
[
ω(X
′θ∗)2
{
σ2(1, X)
e(X)
+
σ2(0, X)
1− e(X)
}]
.
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Remark 1 We show in the Supplementary Material that b1, → 0, as  → 0. Therefore, the increased
variability due to estimating the support, b′1,I(θ∗)−1b1,, is close to 0 with a small .
Remark 2 The term −b′2,I(θ∗)−1b2, implies that the estimated propensity score increases the precision of
the simple weighting estimator of τ based on the true propensity score, a phenomenon that has previously
appeared in the missing data and causal inference literature (e.g., Rubin and Thomas; 1992; Hahn; 1998;
Abadie and Imbens; 2016).
Theorem 2 Under Assumption 1, τˆaug is asymptotically linear. Moreover,
N1/2(τˆaug − τ)→ N
{
0, σ˜2 + b
′
1I(θ∗)−1b1 + (C0 + C1)′I(θ∗)−1(C0 + C1) + B˜′(C0 − C1)
}
,
in distribution, as N →∞, where b1, is defined in Theorem 1,
σ˜2 = ω(θ
∗)−2E[ω(X ′θ∗)2var{τ(X)}] + ω(θ∗)−2E
[
ω(X
′θ∗)2
{
σ2(1, X)
e(X)
+
σ2(0, X)
1− e(X)
}]
,
Ca = E
{
Xω(X
′θ∗)f(X ′θ∗)
µ˜(a,X)− µ(a,X)
pr(A = a | X)
}
(a = 0, 1),
with µˆ(a,X)→ µ˜(a,X) in probability, for a = 0, 1, and B˜ = b1, − C0 − C1.
Remark 3 If the outcome model is correctly specified, then µ˜(a,X) = µ(a,X) and thus C0 = C1 = 0. Con-
sequently, the asymptotic variance of τˆaug reduces to σ˜2 +b′1I(θ∗)−1b1, which is smaller than the asymptotic
variance of τˆ. Intuitively, by regressing Y on X and A, we use the residual as the new outcome, which in
general has a smaller variance than Y .
Remark 4 Because τˆ and τˆ
aug
 are asymptotically linear, the bootstrap can be used to estimate the variances
of τˆ and τˆ
aug
 (Shao and Tu; 2012). Let S = {X | e(X ′θ∗) = α1 or α2}. If pr(X ∈ S) = 0, we show in
the Supplementary Material that the bootstrap works for the weighting estimator with the indicator function,
which will also be demonstrated in the simulation study.
Remark 5 Although some robust nonparametric methods (Hirano et al.; 2003; Lee et al.; 2010) can be used
for propensity score estimation, the majority of the literature used a parametric generalized linear model.
When the propensity score model is misspecified, the weighting estimators are not consistent to the causal
effect defined on the target population O = {X | α1 ≤ e(X) ≤ α2}. However, our estimators can still be
helpful to inform treatment effects for the population defined as O∗ = {X | α1 ≤ e(X ′θ∗) ≤ α2}, where
e(X ′θ∗) is the propensity score projected to the generalized linear model family. This new study population
is defined as between two hyperplanes of the covariate space, which is just slightly more complicated than
the study population defined by the trees in Traskin and Small (2011) or by the intervals of covariates in
Fogarty et al. (2016). Moreover, the smooth weighting estimators are still asymptotically linear, and again
the bootstrap can be used for constructing confidence intervals. See the Supplementary Material for more
details.
Remark 6 An important issue regarding the smooth weight function is the choice of , which involves a
bias-variance trade-off. On the one hand, the discrepancy between τ and the target parameter τ(O) is
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E{[ω(X ′θ∗) − 1{α1 ≤ e(X ′θ∗) ≤ α2}]τ(X)}. Assuming that τ(X) is integrable, by the Dominated Conver-
gence Theorem, τ converges to τ(O) as  → 0. This implies that our inference based on τˆ or τˆaug , by
choosing a small , can be drawn for τ(O). On the other hand, as  → 0, the smooth weight function (4)
becomes closer to the indicator weight function (1), which increases the variance of the weighting estimators.
In practice, we recommend a sensitivity analysis varying  over a grid, for example, {10−4, 10−5, . . .}, which
will be illustrated in the simulation and application.
4 Simulation
We assess the performance of the new weighting estimators of the average treatment effect over a target
population. We consider X = (X1, X2, X3, X4, X5, X6)′, where X1, X2, and X3 are multivariate normal
with means (0, 0, 0), variances (2, 1, 1) and covariances (1,−1,−0.5), X4 ∼ Uniform[−3, 3], X5 ∼ χ21, and
X6 ∼ Bernoulli(0.5). The treatment indicator A is generated from Bernoulli{e(X)}. We consider four
propensity score deigns:
(P1) e(X) = logit{0.1× (X1 +X2 +X3 +X4 +X5 +X6)},
(P2) e(X) = logit{0.8× (X1 +X2 +X3 +X4 +X5 +X6)},
(P3) e(X) = logit{0.1× (X1 +X22 +X23 +X4 +X5 +X6)},
(P4) e(X) = logit{0.8× (X1 +X22 +X23 +X4 +X5 +X6)}.
(P1) and (P3) represent week separations, and (P2) and (P4) represent strong separations of propensity score
distributions between the treatment and control groups. We consider both linear and nonlinear outcome
designs:
(O1) Y (a) = a(X1 +X2 +X3 −X4 +X5 +X6) + η, with η ∼ N (0, 1), for a = 0, 1,
(O2) Y (a) = a(X1 +X2 +X3)2 + η, with η ∼ N (0, 1), for a = 0, 1.
The target population is represented by O = {X | 0.1 ≤ e(X) ≤ 0.9}, and the estimand of interest is the
average treatment effect over the target population τ(O).
We consider the weighting estimators with the indicator and smooth weight functions, and τ(O) =
[
∑N
i=1 1{Xi ∈ O}]−1
∑N
i=1 1{Xi ∈ O}{Yi(1)− Yi(0)} for benchmark comparison with N = 500. The propen-
sity scores are estimated by a logistic regression model with linear predictors X. Therefore, the propensity
score model is correctly specified under (P1) and (P2) but misspecified under (P3) and (P4). For the aug-
mented weighting estimators, µ(a,X) is estimated by a simple linear regression of Y on X, separately for
A = 0, 1. Therefore, the outcome regression model is correctly specified under (O1) but misspecified under
(O2).
Table 1 shows the simulation results. Under Scenarios i, ii, v and vi when the propensity score model
is correctly specified, the weighting estimators are nearly unbiased of τ(O), and the augmented weighting
estimators are more efficient than the simple weighting estimators. However, under Scenarios iii, iv, vii
and viii when the propensity score model is misspecified, all estimators are biased, even when the outcome
regression model is correctly specified. The weighting estimators with the smooth weight function, τˆ and
τˆaug , show slightly smaller variances than the counterparts with the indicator weight function, τˆ and τˆaug.
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Table 1: Results: mean, variance (var), and variance estimate (ve) based on 100 bootstrap replicates under
eight combinations of the outcome and propensity score designs: for example, (O1)&(P1) means Outcome
Deign (O1) and Propensity Score Design (P1)
Scenario i (O1)&(P1) ii (O1)&(P2) iii (O1)&(P3) iv (O1)&(P4)
 mean var ve mean var ve mean var ve mean var ve
τ(O) 1.46 1.33 1.44 1.37
τˆ(θˆ) – 1.45 0.0341 0.0336 1.33 0.0471 0.0518 1.48 0.0285 0.0282 1.45 0.0399 0.0405
τˆaug(θˆ) – 1.46 0.0282 0.0267 1.32 0.0343 0.0342 1.50 0.0263 0.0253 1.49 0.0331 0.0315
τˆ(θˆ) 10
−4 1.45 0.0333 0.0331 1.33 0.0445 0.0474 1.48 0.0284 0.0278 1.45 0.0386 0.0382
τˆaug (θˆ) 10−4 1.46 0.0280 0.0267 1.33 0.0339 0.0333 1.50 0.0263 0.0252 1.49 0.0327 0.0308
τˆ(θˆ) 10
−5 1.45 0.0339 0.0331 1.33 0.0464 0.0503 1.48 0.0285 0.0281 1.45 0.0394 0.0397
τˆaug(θˆ) 10−5 1.46 0.0282 0.0267 1.32 0.0343 0.0342 1.50 0.0263 0.0253 1.49 0.0331 0.0315
v (O2)&(P1) vi (O2)&(P2) vii (O2)&(P3) viii (O2)&(P4)
τ(O) 7.58 6.69 7.62 5.96
τˆ(θˆ) – 7.58 0.9400 0.8912 6.69 0.8983 0.9811 8.75 0.9201 0.9122 8.93 1.4198 1.3808
τˆaug(θˆ) – 7.59 0.8538 0.7652 6.67 0.7919 0.8417 8.82 0.8493 0.7925 9.06 1.2260 1.0958
τˆ(θˆ) 10
−4 7.57 0.8861 0.8408 6.70 0.8528 0.8967 8.75 0.9106 0.8828 8.94 1.3418 1.2842
τˆaug (θˆ) 10−4 7.58 0.8268 0.7473 6.68 0.7663 0.7941 8.82 0.8441 0.7839 9.07 1.1896 1.0554
τˆ(θˆ) 10
−5 7.57 0.9203 0.8732 6.69 0.8879 0.9525 8.75 0.9192 0.9020 8.93 1.3997 1.3479
τˆaug (θˆ) 10−5 7.59 0.8405 0.7591 6.68 0.7868 0.8249 8.82 0.8474 0.7896 9.06 1.2171 1.0824
Moreover, as  becomes smaller, the performances of τˆ and τˆ
aug
 become closer to those of τˆ and τˆaug. The
bootstrap works well with the variance estimates close to the true variances for all estimators.
5 The National Health and Nutrition Examination Survey Data
We examine a data set from the 2007–2008 U.S. National Health and Nutrition Examination Survey to
estimate the causal effect of smoking on blood lead levels (Hsu and Small; 2013). The data set includes 3340
subjects consisting of 679 smokers, denoted as A = 1, and 2661 nonsmokers, denoted as A = 0. The outcome
variable Y is the measured lead level in blood, with the observed range from 0.18 ug/dl to 33.10 ug/dl. The
covariate vector X includes age, income-to-poverty level, gender, education and race.
The propensity score is estimated by a logistic regression model with linear predictors including all
covariates. To help address lack of overlap, for the average smoking effect, because there is little overlap for
the propensity score less than 0.05 and greater than 0.6, we restrict our estimand to the target population
O = {X | 0.05 ≤ e(X) ≤ 0.6}. This results in removal of 794 subjects, with 111 smokers and 683 non-
smokers. Thus, the analysis sample includes 2546 subjects, with 568 smokers and 1978 non-smokers. We
consider the weighting estimators using both the indicator and smooth weight functions with  = 10−4 and
 = 10−5. For the augmented weighting estimator, we consider the outcome model to be a linear regression
model adjusting for all covariates, separately for A = 0, 1.
Table 2 shows the results from the estimators for the average smoking effect based on the trimmed
samples. The weighting estimators with the smooth weight function are close to the counterparts with the
indicator weight function, but have slightly smaller standard errors. The smooth weighting estimators are
insensitive to the choice of . From the results, on average, smoking increases the lead level in blood at least
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Table 2: Estimate, standard error based on 100 bootstrap replicates, and 95% confidence interval
 estimate s.e. 95% c.i. estimate s.e. 95% c.i.
τˆ(θˆ) – 0.646 0.135 (0.376, 0.916) τˆaug(θˆ) 0.765 0.107 (0.552, 0.978)
τˆ(θˆ) 10
−4 0.661 0.124 (0.412, 0.909) τˆaug (θˆ) 0.763 0.105 (0.554, 0.973)
τˆ(θˆ) 10
−5 0.632 0.133 (0.366, 0.899) τˆaug (θˆ) 0.754 0.105 (0.543, 0.964)
by 0.65 over the target population with 0.05 ≤ e(X) ≤ 0.6.
6 Extension to the average treatment effect on the treated
Another estimand of interest is the average treatment effect for the treated τATT = E{Y (1) − Y (0) | A =
1} = E{τ(X) | A = 1}. Similar to Crump et al. (2009), if σ2(1, X) = σ2(0, X), we can show that the optimal
overlap for estimating τATT is of the form O = {X | 1 − e(X) ≥ α} for some α, for which the estimators
have the smallest asymptotic variance. Intuitively, for the treated units with e(X) close to 1, there are few
similar units in the control group that can provide adequate information to infer their Y (0)’s. Therefore, it
is reasonable to drop these units with e(X) close to 1 when inferring τATT. We give a formal discussion in
the Supplementary Material.
By restricting the focus to the optimal set O = {X | 1 − e(X) ≥ α}, the estimand of interest be-
comes τATT(O) = E{τ(X) | A = 1, X ∈ O}. We propose two estimators with smooth inclusion weights
ωATT,(X
′θˆ) = Φ{1− α− e(X ′i θˆ)}e(X ′i θˆ):
τˆATT, =
∑N
i=1 ωATT,(X
′θˆ)τˆ(Xi)∑N
i=1 ωATT,(X
′θˆ)
, τˆaugATT, =
∑N
i=1 ωATT,(X
′θˆ)τˆaug(Xi)∑N
i=1 ωATT,(X
′θˆ)
,
which are (2) and (3) with ω(X ′θˆ) replaced by ωATT,(X ′θˆ). Therefore, the asymptotic properties for τˆATT,
and τˆaugATT, can be derived similarly as in Theorems 1 and 2. In particular, the asymptotic linearity enables
the bootstrap for inference.
Define b˜1, and b˜2, as the analogs of b1, and b2, with weights ωATT,(X ′θˆ). In contrast to Remark 1, for
τATT, b˜1, does not converge to 0 as  → 0. The correction term in the asymptotic variance formula due to
the estimated propensity score instead of the true propensity score, b˜′1,I(θ∗)−1b˜1, − b˜′2,I(θ∗)−1b˜2,, can be
negative, zero, or positive. Ignoring the uncertainty in the estimated propensity score, the inference can be
either conservative or anti-conservative for τATT, which differs from the inference for τ . This fundamental
difference also appeared for matching estimators (Abadie and Imbens; 2016), which highlights the importance
of incorporating the uncertainty in the design stage especially for τATT.
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Supplementary Material
Section S7 gives all the proofs, and Section S8 extends the theory to the average treatment effect on the
treated.
Below we use C ∼= D for C = D +Op(N−1/2). Because θˆ is the solution to the score equation S(θ) = 0,
under certain regularity conditions, θˆ − θ∗ = J (θ∗)−1S(θ∗) + op(N−1/2), where J (θ∗) = E{∂S(θ∗)/∂θ′}
(van der Vaart; 2000). When the propensity model is correctly specified, then J (θ∗) = I(θ∗); but when the
propensity score model is misspecified, J (θ∗) is not necessarily equal to I(θ∗).
S7 Proofs
S7.1 Proof of Theorem 1
We write
τˆ = τˆ(θˆ)
∼= τˆ(θ∗) + E
{
∂τˆ(θ
∗)
∂θ′
}
(θˆ − θ∗) (S1)
∼= 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
{
AiYi
e(X ′iθ∗)
− (1−Ai)Yi
1− e(X ′iθ∗)
}
+ E
{
∂τˆ(θ
∗)
∂θ′
}
I(θ∗)−1S(θ∗) (S2)
=
1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
{
AiYi
e(X ′iθ∗)
− (1−Ai)Yi
1− e(X ′iθ∗)
}
+B′
1
N
N∑
i=1
Xi
Ai − e(X ′iθ∗)
e(X ′iθ∗){1− e(X ′iθ∗)}
f(X ′iθ
∗),
where (S1) follows from the Taylor expansion, (S2) follows from θˆ − θ∗ ∼= I(θ∗)−1S(θ∗) and
B′ = E
{
∂τˆ(θ
∗)
∂θ′
}
I(θ∗)−1. (S3)
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Therefore, the asymptotic linearity of τˆ follows. Moreover,
N1/2(τˆ − τ) ∼= N−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
[
Ai{Yi − µ(Ai, Xi)}
e(X ′iθ∗)
− (1−Ai){Yi − µ(Ai, Xi)}
1− e(X ′iθ∗)
]
+N−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
({Ai − e(X ′iθ∗)}[µ(Ai, Xi)− µ{Ai, e(X ′iθ∗)}]
e(X ′iθ∗){1− e(X ′iθ∗)}
)
+N−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
[{Ai − e(X ′iθ∗)}µ{Ai, e(X ′iθ∗)}
e(X ′iθ∗){1− e(X ′iθ∗)}
− τ{e(X ′iθ∗)}
]
+N−1/2
N∑
i=1
[
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
τ{e(X ′iθ∗)} − τ
]
+N−1/2
N∑
i=1
B′Xi
Ai − e(X ′iθ∗)
e(X ′iθ∗){1− e(X ′iθ∗)}
f(X ′iθ
∗),
= T0 + T1 + T2 + T3,
where τ{e(X ′θ∗)} = E{Y (1)− Y (0) | e(X ′θ∗)}, and by grouping different terms,
T0 = N
−1/2
N∑
i=1
[
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
τ{e(X ′iθ∗)} − τ
]
,
T1 = N
−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
[{Ai − e(X ′iθ∗)}µ{Ai, e(X ′iθ∗)}
e(X ′iθ∗){1− e(X ′iθ∗)}
− τ{e(X ′iθ∗)}
]
+N−1/2
N∑
i=1
B′E{Xi | e(X ′iθ∗)}
Ai − e(X ′iθ)
e(X ′iθ){1− e(X ′iθ)}
f(X ′iθ
∗),
T2 = N
−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
({Ai − e(X ′iθ∗)}[µ(Ai, Xi)− µ{Ai, e(X ′iθ∗)}]
e(X ′iθ∗){1− e(X ′iθ∗)}
)
+N−1/2
N∑
i=1
B′[Xi − E{Xi | e(X ′iθ∗)}]
Ai − e(X ′iθ∗)
e(X ′iθ∗){1− e(X ′iθ∗)}
f(X ′iθ
∗),
and
T3 = N
−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
[
Ai{Yi − µ(Ai, Xi)}
e(X ′iθ∗)
− (1−Ai){Yi − µ(Ai, Xi)}
1− e(X ′iθ∗)
]
. (S4)
Define
F0 =
{
X ′1θ
∗, . . . , X ′Nθ
∗} , F1 = {A1, . . . , AN , X ′1θ∗, . . . , X ′Nθ∗} ,
F2 =
{
A1, . . . , AN , X
′
1θ
∗, . . . , X ′Nθ
∗, X1, . . . , XN
}
.
By conditioning arguments, E(T0) = 0, for k = 1, . . . , 3, E(Tk) = E{E(Tk | Fk−1)} = 0, and for k = 1, . . . , 3,
cov(T0, Tk) = cov{E(T0 | F0), E(Tk | F0)}+ E{cov(T0, Tk | F0)}
= cov{E(T0 | F0), 0}+ E{0} = 0,
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for k = 2, 3,
cov(T1, Tk) = cov{E(T1 | F1), E(Tk | F1)}+ E{cov(T1, Tk | F1)}
= cov{E(T1 | F1), 0}+ E{0} = 0,
and
cov(T2, T3) = cov{E(T2 | F2), E(T3 | F2)}+ E{cov(T2, T3 | F2)}
= cov{E(T2 | F2), 0}+ E{0} = 0.
Also, we calculate the variances of Ti, for i = 0, . . . , 3, as follows. For T0,
var(T0) = E(T
2
0 ) =
E
{
ω(X
′θ∗)2var[τ{e(X ′θ∗)}]}
E{ω(X ′θ∗)}2 .
For T1,
var(T1) = E{var(T1 | F0)} = E{E(T 21 | F0)}
=
1
E{ω(X ′θ∗)}2E{ω(X
′θ∗)2
[{
1− e(X ′θ∗)
e(X ′θ∗)
}1/2
µ{1, e(X ′θ∗)}
+
{
e(X ′θ∗)
1− e(X ′θ∗)
}1/2
µ{0, e(X ′θ∗)}
]2
+ 2
1
E{ω(X ′θ∗)}B
′E{ω(X ′θ∗)E{X | e(X ′θ∗)}
×
[
µ{1, e(X ′θ∗)}
e(X ′θ∗)
+
µ{0, e(X ′θ∗)}
1− e(X ′θ∗)
]
f(X ′θ∗)}
+ B′E
[
f(X ′θ∗)2
E{X | e(X ′θ∗)}E{X ′ | e(X ′θ∗)}
e(X ′θ∗){1− e(X ′θ∗)}
]
B.
For T2,
var(T2) = E{var(T2 | F1)} = E{E(T 22 | F1)}
=
1
E{ω(X ′θ∗)}2E
{
ω(X
′θ∗)2
[
σ2{1, e(X ′θ∗)}
e(X ′θ∗)
+
σ2{0, e(X ′θ∗)}
1− e(X ′θ∗)
]}
+2
1
E{ω(X ′θ∗)}B
′E
{
ω(X
′θ∗)f(X ′θ∗)
[
cov{X,µ(1, X) | e(X ′θ∗)}
e(X ′θ∗)
+
cov{X,µ(0, X) | e(X ′θ∗)}
1− e(X ′θ∗)
]}
+B′E
[
f(X ′θ∗)2
var{X | e(X ′θ∗)}
e(X ′θ∗){1− e(X ′θ∗)}
]
B.
For T3,
var(T3) = E{var(T3 | F2)} = E{E(T 23 | F2)}
∼= 1
E{ω(X ′θ∗)}2E
[
ω(X
′θ∗)2
{
σ21(X)
e(X ′θ∗)
+
σ20(X)
1− e(X ′θ∗)
}]
.
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Because
∂τˆ(θ
∗)
∂θ′
=
1
N
N∑
i=1
∂
∂θ′
[
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
]{
AiYi
e(X ′iθ∗)
− (1−Ai)Yi
1− e(X ′iθ∗)
}
− 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
[
AiYi
e(X ′iθ∗)2
+
(1−Ai)Yi
{1− e(X ′iθ∗)}2
]
f(X ′iθ
∗)Xi,
we have
E
{
∂τˆ(θ
∗)
∂θ
}
= E
(
∂
∂θ
[
ω(X
′θ∗)
E{ω(X ′θ∗)}
]
τ(X)
)
− 1
E{ω(X ′θ∗)}E
{
ω(X
′θ∗)f(X ′θ∗)
×
[
E{X,µ(1, X) | e(X ′θ∗)}
e(X ′θ∗)
+
E{X,µ(0, X) | e(X ′θ∗)}
1− e(X ′θ∗)
]}
= b1, − b2,,
where b1, and b2, are defined in Theorem 1. Therefore, according to (S3), B = (b1, − b2,)′I(θ∗)−1. As a
result,
var(T0) + var(T1) + var(T2) + var(T3)
=
1
E{ω(X ′θ∗)}2E{ω(X
′θ∗)2var[τ{e(X ′θ∗)}]} (S5)
+
1
E{ω(X ′θ∗)}2E
{
ω(X
′θ∗)2
[{
1− e(X ′θ∗)
e(X ′θ∗)
}1/2
µ{1, e(X ′θ∗)}
+
{
e(X ′θ∗)
1− e(X ′θ∗)
}1/2
µ{0, e(X ′θ∗)}
]2
+
1
E{ω(X ′θ∗)}2E
{
ω(X
′θ∗)2
[
σ2{1, e(X ′θ∗)}
e(X ′θ∗)
+
σ2{0, e(X ′θ∗)}
1− e(X ′θ∗)
]}
+
1
E{ω(X ′θ∗)}2E
[
ω(X
′θ∗)2
{
σ2(1, X)
e(X ′θ∗)
+
σ2(0, X)
1− e(X ′θ∗)
}]
(S6)
+2
1
E{ω(X ′θ∗)}B
′E
{
ω(X
′θ∗)f(X ′θ∗)
[
E{Xµ(1, X) | e(X ′θ∗)}
e(X ′θ∗)
+
E{Xµ(0, X) | e(X ′θ∗)}
1− e(X ′θ∗)
]}
+B′I(θ∗)B
= σ2 + b
′
1,I(θ∗)−1b1, − b′2,I(θ∗)−1b2,,
where σ2 is defined as the terms from (S5) to (S6), and the last equality follows by plugging the expression
of B,
2B′b2, +B′I(θ∗)B = 2b′1,I(θ∗)−1b2, − 2b′2,I(θ∗)−1b2, + (b1, + b2,)′I(θ∗)−1(b1, + b2,)
= b′1,I(θ∗)−1b1, − b′2,I(θ∗)−1b2,.
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Moreover, σ2 can be further simplified as
σ2 =
1
E{ω(X ′θ∗)}2E[ω(X
′θ∗)2var{τ(X)}]
+
1
E{ω(X ′θ∗)}2E
{
ω(X
′θ∗)2
[{
1− e(X ′θ∗)
e(X ′θ∗)
}1/2
µ(1, X)2
+
{
e(X ′θ∗)
1− e(X ′θ∗)
}1/2
µ(0, X)
]2 (S7)
+
1
E{ω(X ′θ∗)}2E
[
ω(X
′θ∗)2
{
σ2(1, X)
e(X ′θ∗)
+
σ2(0, X)
1− e(X ′θ∗)
}]
. (S8)
Finally, the Central Limit Theorem implies
N1/2(τˆ − τ)→ N
{
0, σ2 + b
′
1,I(θ∗)−1b1, − b′2,I(θ∗)−1b2,
}
,
in distribution, as N →∞.
S7.2 Proof of Theorem 2
First, τˆaug(Xi) can also be written as
τˆaug(Xi) =
[
AiYi
e(X ′i θˆ)
+
{
1− Ai
e(X ′i θˆ)
}
µˆ(1, Xi)
]
−
[
(1−Ai)Yi
1− e(X ′i θˆ)
+
{
1− 1−Ai
1− e(X ′i θˆ)
}
µˆ(0, Xi)
]
.
Let µˆ(Ai, Xi) converge to µ˜(Ai, Xi) as N → ∞. If the model for µ(Ai, Xi) is correctly specified,
µ˜(Ai, Xi) = µ(Ai, Xi).
Write
τˆaug = τˆ
aug
 (θˆ)
∼= τˆaug (θ∗) + E
{
∂τˆaug (θ∗)
∂θ′
}
(θˆ − θ∗)
∼= 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)} τˆ
aug(Xi) + E
{
∂τˆaug (θ∗)
∂θ′
}
I(θ∗)−1S(θ∗)
∼= 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
[
AiYi
e(Xi)
+
{
1− Ai
e(Xi)
}
µ˜(1, Xi)
]
− 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
[
(1−Ai)Yi
1− e(Xi) +
{
1− 1−Ai
1− e(Xi)
}
µ˜(0, Xi)
]
+B˜′
1
N
N∑
i=1
Xi
Ai − e(X ′iθ∗)
e(X ′iθ∗){1− e(X ′iθ∗)}
f(X ′iθ
∗),
where
B˜′ = E
{
∂τˆaug (θ∗)
∂θ′
}
I(θ∗)−1. (S9)
13
Therefore, the asymptotic linearity of τˆaug follows. Moreover,
N1/2(τˆaug − τ)
∼= N−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
[
Ai{Yi − µ(Ai, Xi)}
e(X ′iθ∗)
− (1−Ai){Yi − µ(Ai, Xi)}
1− e(X ′iθ∗)
]
+N−1/2
N∑
i=1
[
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
τ(Xi)− τ
]
+N−1/2
N∑
i=1
B˜′Xi
Ai − e(X ′iθ∗)
e(X ′iθ∗){1− e(X ′iθ∗)}
f(X ′iθ
∗),
+N−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
{
1− Ai
e(Xi)
}
{µ˜(1, Xi)− µ(1, Xi)}
+N−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
{
1− 1−Ai
1− e(Xi)
}
{µ˜(0, Xi)− µ(0, Xi)}
= T˜3 + T˜0 + T˜1 + T˜2,
where T˜3 = T3 is defined in (S4),
T˜0 = N
−1/2
N∑
i=1
[
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
τ(Xi)− τ
]
,
T˜1 = N
−1/2
N∑
i=1
B˜′Xi
Ai − e(X ′iθ)
e(X ′iθ){1− e(X ′iθ)}
f(X ′iθ
∗),
T˜2 = N
−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
{
1− Ai
e(Xi)
}
{µ˜(1, Xi)− µ(1, Xi)}
+N−1/2
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
{
1− 1−Ai
1− e(Xi)
}
{µ˜(0, Xi)− µ(0, Xi)}.
By the same argument as in the proof of Theorem 1, E(T˜j) = 0, for j = 0, . . . , 3, and cov(T˜j , T˜k) = 0 for all
j 6= k expect cov(T˜1, T˜2). Moreover,
var(T˜3) + var(T˜0) + var(T˜1) + var(T˜2) + 2cov(T˜1, T˜2)
=
1
E{ω(X ′θ∗)}2E
[
ω(X
′θ∗)2
{
σ2(1, X)
e(X ′θ∗)
+
σ2(0, X)
1− e(X ′θ∗)
}]
+
1
E{ω(X ′θ∗)}2E[ω(X
′θ∗)2var{τ(X)}] + B˜′I(θ∗)B˜
+
1
E{ω(X ′θ∗)}2E
{
ω(X
′θ∗)2
[{
1− e(X ′θ∗)
e(X ′θ∗)
}1/2
{µ˜(1, X)− µ(1, X)}
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−
{
e(X ′θ∗)
1− e(X ′θ∗)
}1/2
{µ˜(0, X)− µ(0, X)}
]2
+
1
E{ω(X ′θ∗)}B˜
′E
[
ω(X
′θ∗)Xf(X ′θ∗)
{
− µ˜(1, Xi)− µ(1, Xi)
e(Xi)
}]
+
1
E{ω(X ′θ∗)}B˜
′E
[
ω(X
′θ∗)Xf(X ′θ∗)
{
µ˜(0, X)− µ(0, X)
1− e(Xi)
}]
= σ˜2 + B˜
′I(θ∗)B˜ + B˜′(C0 − C1)
= σ˜2 + b
′
1I(θ∗)−1b1 + (C0 + C1)′I(θ∗)−1(C0 + C1) + B˜′(C0 − C1)
where σ˜2 , C0 and C1 are defined in Theorem 2. Because
∂τˆaug (θ∗)
∂θ
=
1
N
N∑
i=1
∂
∂θ
[
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
]
τˆaug(Xi)
− 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
Xif(X
′
iθ
∗)
Ai{Yi − µ˜(Ai, Xi)}
e(X ′iθ∗)2
− 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′iθ∗)}
Xif(X
′
iθ
∗)
(1−Ai){Yi − µ˜(Ai, Xi)}
{1− e(X ′iθ∗)}2
,
we have
E
{
∂τˆaug (θ∗)
∂θ
}
= E
(
∂
∂θ
[
ω(X
′θ∗)
E{ω(X ′θ∗)}
]
τ(X)
)
− 1
E{ω(X ′iθ∗)}
E
{
ω(X
′
iθ
∗)Xf(X ′θ∗)
µ(1, X)− µ˜(1, X)
e(X ′θ∗)
}
− 1
E{ω(X ′iθ∗)}
E
{
ω(X
′
iθ
∗)Xf(X ′θ∗)
µ(0, X)− µ˜(0, X)
1− e(X ′θ∗)
}
= b1, − C0 − C1.
Therefore,
N1/2(τˆaug − τ)→ N
{
0, σ˜2 + b
′
1I(θ∗)−1b1 + (C0 + C1)′I(θ∗)−1(C0 + C1) + B˜′(C0 − C1)
}
,
in distribution, as N →∞.
S7.3 Proof of Remark 1
We show that
b1, = E
[
∂
∂θ
{
ω(θ
∗)−1ω(X ′θ∗)
}
τ(X)
]
.
goes to zero, as → 0. We note
∂
∂θ
{
ω(θ
∗)−1ω(X ′θ∗)
}
= ω(θ
∗)−2
[
∂ω(X
′θ∗)
∂θ
E{ω(X ′θ∗)} − E
{
∂ω(X
′θ∗)
∂θ
}
ω(X
′θ∗)
]
,
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where
∂ω(X
′θ∗)
∂θ
=
∂
∂θ
[
Φ
{
e(X ′θ∗)− α1
}
Φ
{
α2 − e(X ′θ∗)
}]
= φ
{
e(X ′θ∗)− α1
}
Φ
{
α2 − e(X ′θ∗)
}
f(X ′θ∗)X
−Φ
{
e(X ′θ∗)− α1
}
φ
{
α2 − e(X ′θ∗)
}
f(X ′θ∗)X,
and φ(x) = dΦ(x)/dx. As → 0, φ(x)→ 0 implies that b1, goes to 0.
S7.4 Proof of Remark 4
We write
τˆ = τˆ(θˆ)
∼= τˆ(θ∗) + E
{
∂τˆ(θ∗)
∂θ′
}
(θˆ − θ∗)
∼= 1
N
N∑
i=1
1{α1 ≤ e(X ′iθ∗) ≤ α2}
pr{α ≤ e(X ′θ∗) ≤ 1− α}
{
AiYi
e(X ′iθ∗)
− (1−Ai)Yi
1− e(X ′iθ∗)
}
+ E
{
∂τˆ(θ∗)
∂θ′
}
I(θ∗)−1S(θ∗)
=
1
N
N∑
i=1
1{α1 ≤ e(X ′iθ∗) ≤ α2}
pr{α1 ≤ e(X ′θ∗) ≤ α2}
{
AiYi
e(X ′iθ∗)
− (1−Ai)Yi
1− e(X ′iθ∗)
}
+E
{
∂τˆ(θ∗)
∂θ′
}
1
N
N∑
i=1
Xi
Ai − e(X ′iθ∗)
e(X ′iθ∗){1− e(X ′iθ∗)}
f(X ′iθ
∗).
Let S = {X | e(X ′θ∗) = α1 or α2}. If pr(X ∈ S) = 0, then
E
{
∂τˆ(θ∗)
∂θ′
}
= E
(
∂
∂θ′
[
1{α1 ≤ e(X ′θ∗) ≤ α2}
pr{α1 ≤ e(X ′θ∗) ≤ α2}
]{
AY
e(X ′θ∗)
− (1−A)Y
1− e(X ′θ∗)
})
+E
[
1{α1 ≤ e(X ′θ∗) ≤ α2}
pr{α1 ≤ e(X ′θ∗) ≤ α2}
∂
∂θ′
{
AY
e(X ′θ∗)
− (1−A)Y
1− e(X ′θ∗)
}]
is finite and well-defined, because the only possible problem that prevents the use of the bootstrap is the
derivative of the indicator function with respect to θ which however has a zero measure.
Therefore, τˆ is asymptotically linear. From Shao and Tu (2012), the bootstrap can be used to estimate
var(τˆ). A similar discussion applies to τˆaug.
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S7.5 Proof of Remark 5
We write
τˆ = τˆ(θˆ)
∼= τˆ(θ∗) + E
{
∂τˆ(θ
∗)
∂θ′
}
(θˆ − θ∗)
∼= 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
{
AiYi
e(X ′iθ∗)
− (1−Ai)Yi
1− e(X ′iθ∗)
}
+ E
{
∂τˆ(θ
∗)
∂θ′
}
J (θ∗)−1S(θ∗)
=
1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
{
AiYi
e(X ′iθ∗)
− (1−Ai)Yi
1− e(X ′iθ∗)
}
+Γ′
1
N
N∑
i=1
Xi
Ai − e(X ′iθ∗)
e(X ′iθ∗){1− e(X ′iθ∗)}
f(X ′iθ
∗),
where
Γ′ = E
{
∂τˆ(θ
∗)
∂θ′
}
J (θ∗)−1.
Therefore, the asymptotic linearity of τˆ follows.
Write
τˆaug = τˆ
aug
 (θˆ)
∼= τˆaug (θ∗) + E
{
∂τˆaug (θ∗)
∂θ′
}
(θˆ − θ∗)
∼= 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)} τˆ
aug(Xi) + E
{
∂τˆaug (θ∗)
∂θ′
}
J (θ∗)−1S(θ∗)
∼= 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
[
AiYi
e(Xi)
+
{
1− Ai
e(Xi)
}
µ˜(1, Xi)
]
− 1
N
N∑
i=1
ω(X
′
iθ
∗)
E{ω(X ′θ∗)}
[
(1−Ai)Yi
1− e(Xi) +
{
1− 1−Ai
1− e(Xi)
}
µ˜(0, Xi)
]
+Γ˜′
1
N
N∑
i=1
Xi
Ai − e(X ′iθ∗)
e(X ′iθ∗){1− e(X ′iθ∗)}
f(X ′iθ
∗),
where
Γ˜′ = E
{
∂τˆaug (θ∗)
∂θ′
}
J (θ∗)−1.
Therefore, the asymptotic linearity of τˆaug follows.
The asymptotic linearity of the weighting estimators allows for the bootstrap to construct confidence
intervals.
S8 Average treatment effect on the treated
S8.1 Notation, Assumptions and Extension of Crump et al. (2009)
Another estimand of interest is the average treatment effect for the treated τATT = E{Y (1) − Y (0) | A =
1} = E{τ(X) | A = 1}. The outcome distribution for the treated is empirically identifiable, because
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E{Y (1) | A = 1} = E(Y | A = 1). Therefore, Assumptions 1 and 2 can be weakened (Heckman et al.; 1997).
Assumption S3 Y (0)⊥A | X.
Assumption S4 There exists a constant c such that with probability 1, e(X) ≤ c < 1.
A simple weighting estimator (Hirano et al.; 2003; Mercatanti and Li; 2014; Shinozaki and Matsuyama;
2015) is
τˆATT =
∑N
i=1AiYi∑N
i=1 e(X
′
i θˆ)
−
∑N
i=1(1−Ai)Yie(X ′i θˆ)/{1− e(X ′i θˆ)}∑N
i=1 e(X
′
i θˆ)
=
∑N
i=1 e(X
′
i θˆ)τˆ(Xi)∑N
i=1 e(X
′
i θˆ)
, (S10)
which is a special case of the weighting estimator (4) by choosing ω(X ′i θˆ) = e(X
′
i θˆ). Analogously, the
augmented weighting estimator (Mercatanti and Li; 2014) is
τˆaugATT =
∑N
i=1 e(X
′
i θˆ)τˆ
aug(Xi)∑N
i=1 e(X
′
i θˆ)
. (S11)
There is a limited literature dealing with lack of overlap for τATT when Assumption S4 may not hold.
Dehejia and Wahba (1999) suggested dropping all control units with an estimated propensity score lower
than the smallest value for the estimated propensity score among the treated units. Heckman et al. (1997)
and Smith and Todd (2005) proposed discarding units with covariate values at which the estimated density is
below some threshold. However, few formal results have been established on properties of these procedures.
Similar to Crump et al. (2009), if σ2(1, X) = σ2(0, X), we can show that the optimal overlap for estimating
τATT is of the form O = {X | 1− e(X) ≥ α} for some α, for which the estimators have smallest asymptotic
variance. Intuitively, for the treated units with e(X) close to 1, there are no similar units in the control
group that can provide adequate information to infer Y (0) for these treated units. Statistically, the control
units with e(X) close to 1 contribute to large weights. Therefore, it is reasonable to drop these units with
e(X) close to 1. By restricting the focus to the optimal set, the estimand of interest becomes τATT(O) =
E{τ(X) | A = 1, X ∈ O}. Below, we formalize this argument.
S8.2 Theory of trimming for the average treatment effect on the treated
Define a general weighting average treatment effect,
τω(O) =
∑
i:Xi∈O ω(Xi)τ(Xi)∑
i:Xi∈O ω(Xi)
. (S12)
According to the technique report in 2006 prior to Crump et al. (2009), the efficiency bound for τω(O) is
Vω(O) = 1
[E{ω(X) | X ∈ O}]2E
[
ω(X)2
{
σ2(1, X)
e(X)
+
σ2(0, X)
1− e(X)
}
| X ∈ O
]
. (S13)
Crump et al. (2009) showed that the optimal set with which τˆω(O) achieves the smallest asymptotic variance
over all choices of O is
O =
{
x | ω(x)
{
σ2(1, x)
e(x)
+
σ2(0, x)
1− e(x)
}
≤ γ
}
, (S14)
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Table S3: Estimate, standard error based on 100 bootstrap replicates, and 95% confidence interval
 estimate s.e. 95% c.i. estimate s.e. 95% c.i.
τˆATT(θˆ) – 0.796 0.103 (0.591, 1.001) τˆ
aug
ATT(θˆ) 0.793 0.088 (0.616, 0.970)
τˆATT,(θˆ) 10
−4 0.796 0.102 (0.593, 0.999) τˆaugATT,(θˆ) 0.792 0.088 (0.616, 0.968)
τˆATT,(θˆ) 10
−5 0.796 0.109 (0.579, 1.013) τˆaugATT,(θˆ) 0.793 0.088 (0.617, 0.968)
where γ is defined through the following equation:
γ = 2
E
[
ω2(X)
{
σ2(1,X)
e(X) +
σ2(0,X)
1−e(X)
}
| ω(X)
{
σ2(1,X)
e(X) +
σ2(0,X)
1−e(X)
}
≤ γ
]
E
[
ω(X) | ω(X)
{
σ2(1,X)
e(X) +
σ2(0,X)
1−e(X)
}
≤ γ
] . (S15)
We identify that the weighting estimator for the average treatment effect on the treated is (S12) with ω(X) =
e(X). Assuming that σ2(1, X) = σ2(0, X) = σ2, the optimal set (S14) reduces to O = {x | 1 − e(x) ≥ α}
with the cut-off value α = σ2/γ. In practice, α can be determined by the smallest value of α that satisfy the
empirical estimate of equation (S15):
1
α
= 2
∑N
i=1 e
2(Xi)
{
1
e(Xi)
+ 11−e(Xi)
}
1{1− e(Xi) ≥ α}∑N
i=1 e(Xi)1{1− e(Xi) ≥ α}
.
The choice of α in O = {X | 1 − e(X) ≥ α} has two opposite effects on the asymptotic variance in (S13).
On the one hand, as α increases, we reduce the denominator of the right hand side of (S13), [E{ω(X) |
X ∈ O}]2 = E[{e(X) | X ∈ O}]2, and therefore increase the asymptotic variance. On the other hand, as α
increases, we decrease the numerator of the right hand side of (S13),
E
[
ω(X)2
{
σ2(1, X)
e(X)
+
σ2(0, X)
1− e(X)
}
| X ∈ O
]
= E
[
e(X)σ2(1, X) +
e(X)2σ2(0, X)
1− e(X) | X ∈ O
]
,
and therefore decrease the asymptotic variance. The optimal value of α balances the two effects.
S8.3 The National Health and Nutrition Examination Survey Data
For the average smoking effect on the smokers, subjects are trimmed if their estimated propensity score is
greater than 0.7. This results in removal of 36 subjects, with 29 smokers and 7 non-smokers. Thus, the
analysis sample includes 3304 subjects, with 650 smokers and 2654 non-smokers. Following the main paper
for the average treatment effect, we consider the weighting estimators using both the indicator and smooth
weight functions with  = 10−4 and  = 10−5. For the augmented weighting estimator, we consider the
outcome model to be a linear regression model adjusting for all covariates, separately for A = 0, 1.
Table S3 shows the results from the estimators for the average smoking effect on the smokers based on
the trimmed samples. The weighting estimators with the smooth weight function are close to the counter-
parts with the indicator weight function, but have slightly smaller standard errors. The smooth weighting
estimators are insensitive to the choice of . From the results, on average, smoking increases the lead level in
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blood at least by 0.79 for smokers with e(X) ≤ 0.7.
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